Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Managing disease

This page shows the latest Managing disease news and features for those working in and with pharma, biotech and healthcare.

Keytruda now available for untreated metastatic lung cancer patients via Cancer Drugs Fund

Keytruda now available for untreated metastatic lung cancer patients via Cancer Drugs Fund

It has been recommended for this patient group, only if Keytruda is stopped at 2 years of uninterrupted treatment or earlier if the disease progresses. ... particularly hard to treat forms of this disease," said Louise Houson, UK managing director, MSD.

Latest news

  • Great Expectations Great Expectations

    Consider the case of John and Maria. They both have Parkinson’s disease. ... Given the choice between a definite state of living with Parkinson’s disease and managing symptoms through usual standard-of-care drug therapy or the ‘gamble’ of an

  • Teva’s migraine injection approved in Europe Teva’s migraine injection approved in Europe

    as greater flexibility in managing this unpredictable disease.”. ... Austedo  for tardive dyskinesia and chorea associated with Huntington’s disease to achieve rapid take up, with both treatments now launched.

  • NICE says no to AZ and Vifor’s rival hyperkalaemia drugs NICE says no to AZ and Vifor’s rival hyperkalaemia drugs

    Most common in patients with poor kidney function, heart failure or liver disease, hyperkalemia can be fatal, and patients have had few options for treatment until now. ... The companies argue that this exposes patients to cardiovascular disease risk,

  • Roche wins CHMP backing for Hemlibra Roche wins CHMP backing for Hemlibra

    disease burden of managing the disease. ... The CHMP’s recommendation is based on the results of two phase III clinical studies for people with this particular disease indication.

  • Sanofi looks to mobile data to power behavioural analysis Sanofi looks to mobile data to power behavioural analysis

    The three-year partnership aims to increase Sanofi’s understanding of disease burden and develop solutions from the data that will improve therapeutic outcomes. ... We can then use those insights to support patients and healthcare professionals in

More from news
Approximately 0 fully matching, plus 25 partially matching documents found.

Latest Intelligence

  • AstraZeneca’s focus on diagnosing and managing chronic kidney disease AstraZeneca’s focus on diagnosing and managing chronic kidney disease

    they have it because, in the milder stages of the disease, it is usually asymptomatic. ... Of course, helping someone manage a chronic disease is about more than providing new treatment options.

  • Taking a holistic approach to patient care Taking a holistic approach to patient care

    Within some disease areas, holistic needs are considered an important part of treatment plans. ... Uncovering the issues and concerns patients and carers may have about managing a disease and how this fits into day-to-day life will help companies produce

  • Keeping up the fight against HIV and using the lessons to tackle other threats Keeping up the fight against HIV and using the lessons to tackle other threats

    over 50 and prone to other medical conditions such as heart disease and cancer. ... We have a lot of people at Gilead who have worked across Europe in HIV nursing and med- icine and know patients managing the disease so we can prioritise the projects

  • The patient’s world is ‘messy’ The patient’s world is ‘messy’

    The patient world is multidimensional and what may seem irrelevant, clinically, may be crucial to managing and treating a disease optimally. ... The emotional and social impact of the disease is left out in order to try and speak the HCP’s

  • The EarthWorks: New ways to improve patient care The EarthWorks: New ways to improve patient care

    Keeping people well and preventing illness. Technology is only interesting socially when it is boring technologically; we have to have scale to begin to prevent disease on a population level. ... Managing disease and improving patient outcomes. We can

More from intelligence
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest appointments

  • Cidara Therapeutics makes senior appointments Cidara Therapeutics makes senior appointments

    He also joins from Merck, where he has served as senior scientific director and team leader, managing programmes in areas including infectious disease, metabolic syndrome and thrombosis disease.

  • New medical communications head for S&H New medical communications head for S&H

    In her new role at S&H Pearson will be responsible for managing its medical communications team and driving its growth in the sector. ... Prior to joining the industry Pearson was in academic research, obtaining a DPhil from the University of Oxford

  • GCI Health backs growth with new talent GCI Health backs growth with new talent

    Goldberg joins from Ruder Finn, where she was a senior vice president, managing global clients across multiple disease areas.

  • Kane & Finkel announces new European director

    In addition, as director of communications for the UK's Health Education Authority, he also developed public health campaigns for AIDS, smoking cessation, childhood immunisation and heart disease. ... John Kane, principal and managing director of Kane

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....

Quick links